Changes in mortality by cause of death in Polish voivodships

2015 ◽  
Vol 60 (11) ◽  
pp. 30-53
Author(s):  
Wiktoria Wróblewska

This study analyses the avoidable mortality in Poland at the regional level of 16 voivodships over the last two decades, 1991–2010. The author divided the mortality causes into three groups: treatable disease, preventable diseases and ischemic heart disease. We used a decomposition technique to calculate the contribution of changes in mortality from these conditions to changes in life expectancy between birth and age 75 for the two periods 1991–2000 and 2000–2010 by sex and age group. The analyses were based on temporary life expectancy between birth and age 75 (e0–75). Chiang’s method was used for constructing abridged life tables, and Arriaga’s method was used for decomposition. The results revealed differences in the temporary life expectancy level and pace of change between voivodships, causes of deaths and sex.

2020 ◽  
Vol 17 (1) ◽  
Author(s):  
Aleša Lotrič Dolinar ◽  
Jože Sambt

For many decades, life expectancy at birth (e0) in Slovenia has been increasing at a very rapid pace. However, in 2015, e0 declined slightly; it recovered in 2016, but fell again in 2017 for women. In the same period, a pause in declining mortality was observed in numerous developed countries worldwide. It is too early to provide a thorough analysis and firm conclusions, but we shed some light on the topic by decomposing the observed decline in Slovenia by age and cause of death. In particular, using a life table model and life expectancy decomposition technique, we analyse what cause of death for what age group contributed the most to this decline in life expectancy at birth. We show that the main reason for the recent drop in life expectancy at birth in Slovenia was higher mortality due to external causes for men of all ages and due to neoplasms for women above 60 years and men above 50 years.


2022 ◽  
Vol 12 (6) ◽  
pp. 69-72
Author(s):  
Anchal Jaiswal ◽  
Sanjay Kumar Singh ◽  
Seema Joshi

Given increasing evidence, most deaths are due to non-communicable diseases; half of them are the cardiovascular disease. Hridaya is moolasthana of pranvavaha and rasavaha strotas. According to Acharya Sushruta, any condition that produces disturbance in the heart is Hridroga. It is classified into five types. Vataja Hridroga is characterized by Ruja in Urah Pradesha (Pain in the chest region). Vatika type seems to have conceived the disease entity correlated with ischemic heart disease. None of the other Cardiac afflictions appears to have been described under Hridroga. The prevalence rate in the younger age group is increasing day by day so, we need to know the detailed knowledge of vatika hridroga


Curationis ◽  
1981 ◽  
Vol 4 (2) ◽  
Author(s):  
D Nieman

In the Republic of South Africa, ischaemic heart disease is the main cause of death amongst Whites in the age group 20 — 65 years. The percentage for ischaemic heart disease of all deaths from diseases of the circulatory system for Whites in the age group 25 — 34 is 63% for males and 21% for females. In the age group 35 — 44 the percentages are 77% for males and 34% for females (22, p.1025).


Medicina ◽  
2011 ◽  
Vol 47 (9) ◽  
pp. 504 ◽  
Author(s):  
Vilius Grabauskas ◽  
Aldona Gaižauskienė ◽  
Skirmantė Sauliūnė ◽  
Rasa Mišeikytė

The process of the restructuring of health care system in Lithuania demonstrates the need to continue the monitoring of changes in avoidable mortality. Objective. To assess the level of avoidable mortality as well as its changes over time in Lithuania during 2001–2008 and to define the impact of avoidable mortality on life expectancy. Material and Methods. The mortality data were taken from the Lithuanian Department of Statistics. Twelve avoidable causes of deaths (treatable and preventable) were analyzed. Mortality trends were assessed by computing the average annual percent change (AAPC). The shortening of average life expectancy was computed from survival tables. Results. During the period 2001–2008, the avoidable mortality was increasing more significantly (AAPC 3.0%, P<0.05) than the overall mortality (AAPC 1.7%, P<0.05) in the population aged 5–64 years. The increasing trend was mainly determined by mortality from preventable diseases (AAPC 4.6%, P<0.05). The avoidable causes of death reduced the life expectancy by 1.77 years (preventable by 1.12 and treatable by 0.63 years). Diversity in trends in mortality of different avoidable causes was disclosed. A declining trend in mortality caused by chronic rheumatic heart disease and lung cancer was observed for males (AAPC –22.6% and –2.1%, respectively; P<0.05). However, the mortality caused by liver cirrhosis was increasing for both genders (AAPC 16.1% for males and 17.6% for females, P<0.01) and that caused by tuberculosis – only for females (AAPC 7.8%, P<0.05). Conclusions. An increasing trend in avoidable mortality was observed. Deaths caused by the diseases that could have been prevented had the greatest impact on the increasing mortality and decreasing life expectancy.


Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 3192-3192 ◽  
Author(s):  
Margaret V. Ragni ◽  
Lawrence A. Nichols

Abstract Mortality in individuals with hemophilia is 2.7-fold higher than the general population. By contrast, ischemic heart disease mortality in this group is 60% lower than in the general population. The reason for these differences is not known. While high VIII:C is associated with thrombotic risk, and low VIII:C is associated with bleeding risk, it remains unproven whether low VIII:C is protective against atherosclerosis or cardiovascular morbidity or mortality. We, therefore, conducted a case-control study to compare coronary atherosclerosis at autopsy in 14 hemophilic men who died between 1983 and 1992, on whom autopsies were available, and 42 HIV-negative age-, gender-, and race-matched non-hemophilic controls. The mean age at death in hemophilic cases was 40 ± 4 yr (19–74), as compared with 41 ± 2 yr (18 to 75) in the controls, p > 0.25. The cause of death in cases was AIDS in 7 (50.0%), hepatitis C liver disease in 4 (28.6%), CNS bleeding in 2 (14.3%), and cancer in 1 (7.1%). The cause of death in controls was cardiopulmonary disease in 14 (33.3%), infection in 13 (30.9%), cancer in 4 (9.5%), organ failure in 4 (9.5%), and other in 7 (16.7%). None (0%) of the hemophilia cases had coronary disease symptoms vs. 2 (4.8%) of the controls, p = 0.559. Ten (71.4%) of the cases were HIV-infected, but none had received HAART therapy. Twelve cases had severe hemophilia (VIII < 0.01 U/ml), one moderate disease (VIII = 0.01–0.04 U/ml), and one mild disease (VIII ≥ 0.05 U/ml). None of the cases had diabetes or hypercholesterolemia (> 220 mg/dl); five (35.7%) were smokers, five (35.7%) were hypertensive (systolic > 140 and/or diastolic > 80 mm Hg), and three (21.4%) were obese (body mass index > 25 kg/m2). Body mass index, mean 23.84 ± 0.84 kg/m2, and blood pressure, mean systolic, 129 ± 6 mm Hg, and mean diastolic, 82 ± 3 mm Hg, increased with age, r = 0.439, r = 0.488, r = 0.209, respectively, but not significantly so, p > 0.05. Intraluminal coronary stenosis was assessed by a semi-quantitative scoring system, with 0 = minimal (< 25%), 1= mild (≥ 25%), 2 = moderate (≥ 50%), and 3 = severe (≥ 75%). Coronary stenosis was detected in 11 of 14 (78.6%) hemophilic cases and in 25 of 42 (59.5%) controls, p = 0.118. There was no difference in the proportion with > 75% narrowing, 2 of 14 (14.3%) cases vs. 9 of 42 (21.4%) controls, respectively, p = 0.272. The overall mean stenosis score in hemophilic cases was 1.1 ± 0.2, not different from that in non-hemophilic controls, 1.2 ± 0.2, p > 0.25. The degree of intraluminal narrowing increased with age in cases, r = 0.773, p < 0.01, and in controls, r = 0.694, p < 0.01. There was no difference between age and coronary narrowing between groups, p = 0.928. In conclusion, the prevalence of coronary atherosclerosis in hemophilic men is comparable to that in age-, gender-, and race-matched non-hemophilic controls. Although factor VIII:C does not appear to promote atherogenesis, it is possible, although not proven, that low or missing VIII:C in hemphilia may be protective against thrombotic occlusion of atherosclerotic vessels by interfering with fibrin formation, thereby affording protection from ischemic heart disease mortality.


2020 ◽  
Vol 222 ◽  
pp. 05008
Author(s):  
Galina Ulivanova ◽  
Olga Fedosova ◽  
Galina Glotova ◽  
Olga Antoshina ◽  
Alexandra Fetisova

The paper presents the results of the analysis of demographic and medico-social data characterizing the dynamics of morbidity and mortality from environmental diseases, in particular, diseases of the cardiovascular system. The trend of negative natural population growth was revealed, amounting to -6.9 per 1,000 persons by 2019. The number of patients with cardiovascular diseases was 13 817,4 persons, with the overwhelming majority of the working-age population (9020,2 persons). Ischemic heart disease had the largest share in the structure of the studied diseases (62,25 %). There was also a decrease in life expectancy over the past 30 years and an increase in mortality of young and middle-aged people.


2021 ◽  
Vol 19 (3) ◽  
pp. 150-154
Author(s):  
Sanjay B Jagtap ◽  

Background: The geriatric population is defined as population aged 60 years and above. The mixed profile of communicable and non-communicable diseases among the elderly population in developing countries places a huge burden on the existing health care delivery system. Present hospital based cross-sectional study was focused on the morbidity profile of the elderly and improve the health care services so as to enable them to lead a productive life. Material and Methods: Present study was single centre, descriptive observational study, conducted in subjects above 60 years and both gender, visiting to OPD and IPD, willing to participate in study after written consent. Results: We included total 200 geriatric population in our study. Majority of them were from 60-70 years age group (50 %) followed by 71-80 years (37%) and 81-90 years age group (13%). Mean age was 70.75±7.25 years. Males were 56.5% and females were 43.5%. Males were predominant in our study with male to female ratio 1.29:1. Most common addiction seen among the patients are tobacco chewing (49.5%) followed by smoking (27%), followed by pan (24.5%), nut (21.5%) and alcohol (10.5%). Family history of diabetes and hypertension was present in 63.5% and 72% cases respectively. Prevalence of cataract as commonest observed morbidity in our study was 60%, DM 37%, hypertension 34%, IHD 33.5%, anemia 21%, hearing loss 11.5% and cancer was 4%. Out of 45 deaths, 44.4% deaths occurred in patients with IHD as risk factor, 26.6% deaths occurred in patients with COPD as risk factor, 22.2% deaths occurred in patients with CVA/stroke as risk factor and 17.8% deaths occurred in patients with AKI as risk factor. So IHD, COPD, CVA and AKI were significantly associated with mortality. Conclusion: Commonly observed morbidities were cataract (60%), diabetes mellitus (37%), hypertension (34%), ischemic heart disease (33.5%) Significant association of mortality was seen with ischemic heart disease, chronic obstructive pulmonary disease, cerebrovascular accident and acute kidney injury.


2013 ◽  
Vol 2013 ◽  
pp. 1-4 ◽  
Author(s):  
Y. E. Razvodovsky

Objective. The aim of the present study was to estimate the premature ischemic heart disease (IHD) mortality attributable to alcohol abuse in Russia on the basis of aggregate-level data of mortality and alcohol consumption. Method. Age-standardized sex-specific male and female IHD mortality data for the period 1980–2005 and data on overall alcohol consumption were analyzed by means of autoregressive integrated moving average (ARIMA) time series analysis. Results. The results of the analysis suggest that 41.1% of all male deaths and 30.7% of female deaths from IHD in Russia could be attributed to alcohol. The estimated alcohol-attributable fraction for men ranged from 24.0% (75+ age group) to 62.0% (15–29 age group) and for women from 20.0% (75+ age group) to 64.0% (30–44 age group). Conclusions. The outcomes of this study provide indirect support for the hypothesis that the high rate of IHD mortality in Russia may be related to alcohol, as indicated by a close aggregate-level association between number of deaths from IHD and overall alcohol consumption per capita.


2020 ◽  
Vol 41 (Supplement_2) ◽  
Author(s):  
A Wals Rodriguez ◽  
C Federero Fernandez ◽  
M.J Rodriguez Puras ◽  
R Garcia Orta ◽  
E Moreno Escobar ◽  
...  

Abstract   The objective of this study is to evaluate mortality, causes and risk factors of death in adults with congenital heart disease (ACHD) and PHT on Pulmonary vasodilator therapy (PVT). Methods 170 cases with PHT were identified in RACCA (Left heart disease were excluded (n=20)). We examined mortality, causes of death and complications during a mean follow-up (FU) of 7.9+4.6 years. For each patient demographic data, shunt location, clinical PHT group and functional class (FC) were collected. In an unselected sample of 103 patients, O2Sat, NT-proBNP, right ventricle function (RV) and 6-minute-test (6min) were retrospectively reviewed at 2 data collection time points: evaluation at baseline and the most recent data preceding death or at last clinical visit. Survival was assessed with Kaplan-Meier curves and differences between groups using the log-rank test. To look for predictors of death, Cox regression analysis was performed. Results Patients with PHT were predominantly women (61%), aged 45 years (IQR 33–58.5). The distribution of PHT group by underlying defects were 58 Eisenmenger (ES) (Complex 50%) and 45 non-ES (pretricuspid 46.7% (p=0,0002). PHT-pretricuspid defects occurred more in women with unrepaired simple defects and at older ages. In the sample, 85% were commenced on therapy with PVT (5% on initial dual therapy). The treated patients presented worse functional situation, more desaturation of O2 and worse TAPSE. In the group of treatment, 53% required treatment escalation during the FU. Initially, 82% were in sinus rhythm, in FC I-II 53% and in FC III-IV 39%. 10% had moderate-severe RV dysfunction. At the last visit, 38% were on monotherapy, 40% on dual therapy and 22% on triple therapy. FC improved from III-IV to I-II in 35% and 79% remained in FC-I-II without clinical deterioration. The Δ6min was +53±72 mts in those patients alive at the end of FU, and −126±26 mts in exitus cases (p=0,003), but O2 saturation did not change significantly. Over the FU, 29 patients died. The main cause of death was heart failure, followed by sudden death. The event-free survival was 84% at 5 years. Survival was significantly worst for patients presenting with arrhythmias and more advanced FC at initiation of PVT and for those who developed RV dysfunction over FU. At multivariate analysis, syndromic forms, pretricuspid shunt, non-ES physiology, PVT and monotherapy at baseline, FC III-IV and desaturation were independent predictors for death. Conclusions Although a positive clinical response was observed, mortality of PHT in CHD under advanced PVT remains high at mid-term FU. Heart failure is the leading cause of death. In terms of mortality, non ES patients and pretricuspid shunts were less responsive to treatment than patients with ES. Our results may suggest that patients with more advanced disease at the initiation of therapies do not respond properly and support the need for early treatment and initial dual therapy. Funding Acknowledgement Type of funding source: None


Sign in / Sign up

Export Citation Format

Share Document